My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 444

    1.

    Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.

    Grounds RM, Bolan C.

    Crit Care. 2005;9 Suppl 5:S29-36. Epub 2005 Oct 7. Review. Erratum in: Crit Care. 2005;9(6):560. PMID: 16221317 [PubMed - indexed for MEDLINE]Related articles

    2.

    Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.

    Mohr AM, Holcomb JB, Dutton RP, Duranteau J.

    Crit Care. 2005;9 Suppl 5:S37-42. Epub 2005 Oct 7. Review.PMID: 16221318 [PubMed - indexed for MEDLINE]Related articles

    3.

    Potential role of recombinant factor VIIa as a hemostatic agent.

    Hedner U, Erhardtsen E.

    Clin Adv Hematol Oncol. 2003 Feb;1(2):112-9. Review.PMID: 16224390 [PubMed - indexed for MEDLINE]Related articles

    4.

    Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.

    Allen GA, Hoffman M, Roberts HR, Monroe DM 3rd.

    Can J Anaesth. 2002 Dec;49(10):S7-14. Review.PMID: 12546000 [PubMed - indexed for MEDLINE]Related articles

    5.

    A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.

    Murkin JM.

    Can J Anaesth. 2002 Dec;49(10):S21-6. Review.PMID: 12546007 [PubMed - indexed for MEDLINE]Related articles

    6.

    Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.

    Brady KM, Easley RB, Tobias JD.

    Paediatr Anaesth. 2006 Oct;16(10):1042-6.PMID: 16972833 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antidotes to haemorrhage: recombinant factor VIIa.

    Kessler CM.

    Best Pract Res Clin Haematol. 2004 Mar;17(1):183-97. Review.PMID: 15171966 [PubMed - indexed for MEDLINE]Related articles

    8.

    Recombinant factor VIIa: a review on its clinical use.

    Franchini M.

    Int J Hematol. 2006 Feb;83(2):126-38. Review.PMID: 16513530 [PubMed - indexed for MEDLINE]Related articles

    9.

    Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII.

    Liebman HA, Chediak J, Fink KI, Galvez AG, Shah PC, Sham RL.

    Am J Hematol. 2000 Mar;63(3):109-13.PMID: 10679799 [PubMed - indexed for MEDLINE]Related articles

    10.

    Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.

    Levi M, Peters M, Büller HR.

    Crit Care Med. 2005 Apr;33(4):883-90. Review.PMID: 15818119 [PubMed - indexed for MEDLINE]Related articles

    11.

    Recombinant factor VIIa: its background, development and clinical use.

    Hedner U.

    Curr Opin Hematol. 2007 May;14(3):225-9. Review.PMID: 17414211 [PubMed - indexed for MEDLINE]Related articles

    12.

    Challenges in the therapeutic use of a "so-called" universal hemostatic agent: recombinant factor VIIa.

    Hoots WK.

    Hematology Am Soc Hematol Educ Program. 2006:426-31. Review.PMID: 17124094 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    To general haemostasis--the evidence-based route.

    Erhardtsen E.

    Pathophysiol Haemost Thromb. 2002;32 Suppl 1:47-52. Review.PMID: 12214148 [PubMed - indexed for MEDLINE]Related articles

    14.

    Recombinant factor VIIa in the treatment of bleeding.

    Midathada MV, Mehta P, Waner M, Fink LM.

    Am J Clin Pathol. 2004 Jan;121(1):124-37. Review.PMID: 14750250 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Recombinant-activated coagulation factor VIIa (NovoSeven): current development.

    Weiskopf RB.

    Vox Sang. 2007 May;92(4):281-8. Review.PMID: 17456151 [PubMed - indexed for MEDLINE]Related articles

    16.

    The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa.

    Negrier C, Hay CR.

    Semin Thromb Hemost. 2000;26(4):407-12. Review.PMID: 11092216 [PubMed - indexed for MEDLINE]Related articles

    17.

    The evidence behind inhibitor treatment with recombinant factor VIIa.

    Ludlam CA.

    Pathophysiol Haemost Thromb. 2002;32 Suppl 1:13-8. Review.PMID: 12214140 [PubMed - indexed for MEDLINE]Related articles

    18.

    Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.

    Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E.

    Can J Anaesth. 2002 Dec;49(10):S15-20.PMID: 12546003 [PubMed - indexed for MEDLINE]Related articles

    19.

    Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors.

    Stephens JM, Joshi AV, Sumner M, Botteman MF.

    Expert Opin Pharmacother. 2007 Jun;8(8):1127-36. Review.PMID: 17516876 [PubMed - indexed for MEDLINE]Related articles

    20.

    Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.

    Mayo A, Misgav M, Kluger Y, Geenberg R, Pauzner D, Klausner J, Ben-Tal O.

    Vox Sang. 2004 Jul;87(1):34-40. Review.PMID: 15260820 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity